SCHEMBL8345551

SCHEMBL8345551

N=C(S)NC1CCCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP3A4 P08684 2/20 0.50
TP53 P04637 1/20 0.50
MAPT P10636 1/20 0.50
KDM4E B2RXH2 1/20 0.50
EPHX2 P34913 1/20 0.50
SIGMAR1 Q99720 3/20 0.44
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
MMP2 P08253 3/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
MMP8 P22894 1/20 0.41
MMP1 P03956 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5324177 1.00 EPHX1 (0.50) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL8299523 0.97
SCHEMBL8299492 0.92
SCHEMBL8299482 0.86
SCHEMBL2740861 0.78 EPHX1 (0.55) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL6440859 0.76 EPHX1 (0.52) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL3915783 0.75 EPHX1 (0.50) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL23736061 0.74 EPHX1 (0.50) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL19359634 0.74 EPHX1 (0.50) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL2233593 0.74 EPHX1 (0.50) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004009121-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING HEPATITIS C VIRAL PROTEASE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-01-29 WO disclosed